Storebrand (OB:STB) Second Quarter 2025 Results
Key Financial Results
- Revenue: kr39.5b (up 113% from 2Q 2024).
- Net income: kr1.20b (down 44% from 2Q 2024).
- Profit margin: 3.0% (down from 12% in 2Q 2024). The decrease in margin was driven by higher expenses.
- EPS: kr2.79 (down from kr4.86 in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Storebrand Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 26%. Earnings per share (EPS) also surpassed analyst estimates by 32%.
Looking ahead, revenue is expected to decline by 66% p.a. on average during the next 3 years, while revenues in the Insurance industry in Europe are expected to grow by 5.4%.
Performance of the market in Norway.
The company's shares are up 3.2% from a week ago.
Risk Analysis
We should say that we've discovered 1 warning sign for Storebrand that you should be aware of before investing here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OB:STB
Storebrand
Provides insurance products and services in Norway, the United States, Germany, Sweden, the United Kingdom, and internationally.
Fair value with low risk.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives
PSP Energy Breaks Key Downtrend, Momentum Building for Further Upside

Blindly Bullish on Indofood CBP Sukses Makmur's 5.3% Revenue Growth

CSL Investment Thesis
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

